{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:07:23Z","timestamp":1757624843744,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2008900"],"award-info":[{"award-number":["2020YFC2008900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cpt.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T16:52:13Z","timestamp":1687193533000},"page":"220-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of diffuse large B-cell lymphoma with interstitial pneumonia"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-3729","authenticated-orcid":false,"given":"Ge","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2022","series-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae): B cell lymphomas, version 3. Plymouth Meeting","key":"10.1016\/j.cpt.2023.06.001_bib1"},{"key":"10.1016\/j.cpt.2023.06.001_bib2","first-page":"1015","article-title":"Interstitial pneumonia in patients with diffuse large B-cell lymphoma receiving RCHOP and RCDOP regimens","volume":"40","author":"Meng","year":"2019","journal-title":"Chin J Hematol"},{"key":"10.1016\/j.cpt.2023.06.001_bib3","first-page":"936","article-title":"The risk factors and clinical features of interstitial pneumonia in B-cell non-Hodgkin's lymphoma patients who were treated with rituximab-CHOP regimen","volume":"24","author":"Wang","year":"2014","journal-title":"China Oncology"},{"key":"10.1016\/j.cpt.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","article-title":"Interstitial pneumonitis related to rituximab therapy","volume":"348","author":"Burton","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cpt.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00277-017-3157-9","article-title":"Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma","volume":"97","author":"Liu","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cpt.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"880144","DOI":"10.3389\/fonc.2022.880144","article-title":"Meta-Analysis of risk factors and incidence of interstitial pneumonia with CHOP-like regimens for non-Hodgkin lymphoma","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"106688","DOI":"10.1016\/j.leukres.2021.106688","article-title":"Not all bad: drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival","volume":"111","author":"Wei","year":"2021","journal-title":"Leuk Res"},{"key":"10.1016\/j.cpt.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cpt.2023.06.001_bib9","first-page":"185362","article-title":"Impact of interstitial pneumonia on the survival and risk factors analysis of patients with hematological malignancy","volume":"2013","author":"Chen","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.cpt.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.3109\/10428194.2015.1029925","article-title":"Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study","volume":"56","author":"Iannitto","year":"2015","journal-title":"Leuk Lymphoma"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:27:07Z","timestamp":1757431627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713223000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2949713223000289"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2023.06.001","relation":{},"ISSN":["2949-7132"],"issn-type":[{"type":"print","value":"2949-7132"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of diffuse large B-cell lymphoma with interstitial pneumonia","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}